Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Phase Ib study of BNP-166 successfully completed

March 27, 2002

Inhibitors of iNOS claimed by AstraZeneca for inflammatory disorders and pain

March 26, 2002

Phase II trial for ISIS-14803 in hepatitis C commences

March 26, 2002

Pantoprazole safely eliminates gastrointestinal bleeding in patient with short bowel syndrome

March 26, 2002

Remicade granted priority review as Crohn's disease monotherapy

March 25, 2002

Minimally invasive treatment for GERD safe and effective in long-term human trial

March 25, 2002

Pegasys recommended for approval in E.U. for chronic hepatitis C

March 25, 2002

Oral entecavir highly effective in transgenic mouse model of HBV infection

March 22, 2002

Prague presentations describe good anti-HBV activity and favorable pharmacokinetics of MIV-210

March 22, 2002

Zelnorm/Zelmac approved in Canada and Brazil

March 20, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 5, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...